Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Dataderm’s Role in Dermatology MIPS Reporting and Quality Improvement
Description
Dataderm is presented as the American Academy of Dermatology’s Qualified Clinical Data Registry and a key tool for dermatology MIPS reporting and quality improvement. The speaker explains that Dataderm predates MIPS but became especially useful after MACRA because it simplifies data collection, avoids manual chart review, and helps practices track performance on dermatology-relevant measures. Dataderm currently offers 17 MIPS measures and 7 QCDR measures, many of them dermatology-specific, covering topics such as skin cancer biopsy reporting, psoriasis care, melanoma, and actinic keratosis. The registry is described as the largest dermatology registry in the world and free to join, with a new platform that is more user-friendly and adds a quality dashboard, data completeness rates, patient-level drill-downs, and better guidance for improvement. The talk highlights that practices often improve once they can see their own data, and notes Dataderm’s growth to over 1,600 practices, 5,070 clinicians, 16 million patients, and 68 million visits. The speaker also introduces MIPS Value Pathways, saying dermatology has an MVP option with fewer required measures, subgroup reporting, and future CMS emphasis, and encourages practices to join Dataderm to support both their own reporting and the specialty’s ability to tell its story through data.
View moreConclusions
- DataDerm is presented as the largest dermatology clinical registry and a central tool for collecting meaningful data to improve care quality.
- Using DataDerm makes MIPS and MVP reporting easier, more transparent, and less burdensome than manual chart review.
- The registry’s measure tracking and new quality dashboard help practices identify performance gaps, distinguish documentation problems from care gaps, and target quality improvement.
- Participation in DataDerm appears to improve performance over time, with measured quality rates rising after practices can see their own data.
- The new DataDerm platform was described as a successful upgrade that improved usability, reporting workflows, and access to patient-level and completeness data.
- DataDerm’s retrospective data capture and growing network of practices create a large, expanding dataset that strengthens specialty-wide benchmarking and research.
- MIPS value pathways are likely to become increasingly important, and DataDerm is positioning itself to support the transition to MVP-based reporting.
- The dermatology MVP simplifies reporting by reducing the number of required measures while adding subgroup reporting and a specialty-specific cost measure.
- Overall, the presentation argues that joining and using DataDerm helps dermatologists meet regulatory requirements while advancing specialty-specific quality measurement and patient care.
- J Am Acad Dermatol. 2024 May;90(5):1002-1005.
- CMS. MIPS Value Pathways (MVPs). Qpp.cms.gov